Pall Corporation (East Hills, NY) has purchased GeneSystems (Bruz, France), a privately held biotechnology company that has developed a molecular diagnostics platform.
The acquisition of GeneSystems, with its patented approach to rapid microbiological detection equipment and disposables, expands Pall’s Total Fluid Management (TFM) capabilities in the $1-billion biopharmaceuticals process monitoring market.
Process monitoring includes the analytical tests required during biopharmaceuticals manufacturing for environmental monitoring, in-process control testing, and finished product release testing. These tests are receiving increased regulatory scrutiny and support under initiatives such as process analytical technology (PAT).
Pall release
